Risk factors for mortality in patients with pulmonary mucormycosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Hyo-Ju | - |
dc.contributor.author | Song, Joon Seon | - |
dc.contributor.author | Choi, Sungim | - |
dc.contributor.author | Jung, Jiwon | - |
dc.contributor.author | Kim, Min Jae | - |
dc.contributor.author | Chong, Yong Pil | - |
dc.contributor.author | Lee, Sang-Oh | - |
dc.contributor.author | Choi, Sang-Ho | - |
dc.contributor.author | Kim, Yang Soo | - |
dc.contributor.author | Woo, Jun Hee | - |
dc.contributor.author | Kim, Sung-Han | - |
dc.date.accessioned | 2021-09-10T06:49:16Z | - |
dc.date.available | 2021-09-10T06:49:16Z | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 0933-7407 | - |
dc.identifier.issn | 1439-0507 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/19486 | - |
dc.description.abstract | Background Pulmonary mucormycosis (PM) represents a serious burden in terms of morbidity and mortality in immunocompromised patients. Studies of prognostic factors in patients with PM are limited and have involved small numbers of patients. Methods Adult patients diagnosed with proven and probable PM according to the modified definitions of the EORTC/MSG 2008 in a tertiary hospital in Seoul, South Korea, between 2008 and 2019 were retrospectively enrolled. Results A total of 49 patients including 31 (63%) with proven PM and 18 (37%) with probable PM were enrolled. The 90-day mortality rate was 49% (24/49). Neutropenia, thrombocytopenia, use of voriconazole at clinical suspicion, positivity of non-sterile culture, use of steroid and treatment without surgery were more common in fatal cases than non-fatal cases. Voriconazole use at clinical suspicion for invasive mould pneumonia (OR 6.91, P = .01) and prolonged neutropenia (OR 4.86, P = .03) were independent risk factors for mortality. Voriconazole use at clinical suspicion was associated with positive galactomannan (GM) assay (OR 5.93, P = .02) and history of invasive pulmonary aspergillosis (OR, 6.88, P = .05). Conclusion About half of the patients with PM died within 90 days of diagnosis, and fatal outcomes were common in patients with prolonged neutropenia and empirical voriconazole use. Caution is needed in using voriconazole even in patients with positive GM results and prior histories of invasive pulmonary aspergillosis in whom PM cannot be ruled out by differential diagnosis. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Blackwell Publishing Inc. | - |
dc.title | Risk factors for mortality in patients with pulmonary mucormycosis | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/myc.13092 | - |
dc.identifier.scopusid | 2-s2.0-85085130252 | - |
dc.identifier.wosid | 000530635000001 | - |
dc.identifier.bibliographicCitation | Mycoses, v.63, no.7, pp 729 - 736 | - |
dc.citation.title | Mycoses | - |
dc.citation.volume | 63 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 729 | - |
dc.citation.endPage | 736 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalResearchArea | Mycology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Mycology | - |
dc.subject.keywordPlus | ASPERGILLOSIS | - |
dc.subject.keywordPlus | ZYGOMYCOSIS | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | ANTIGENEMIA | - |
dc.subject.keywordPlus | INFECTIONS | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordAuthor | galactomannan | - |
dc.subject.keywordAuthor | mortality | - |
dc.subject.keywordAuthor | mucormycosis | - |
dc.subject.keywordAuthor | neutropenia | - |
dc.subject.keywordAuthor | invasive pulmonary aspergillosis | - |
dc.subject.keywordAuthor | polyenes | - |
dc.subject.keywordAuthor | pulmonary mucormycosis | - |
dc.subject.keywordAuthor | voriconazole | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.